Tacrolimus Market Share

Report ID: GMI8362
   |
Published Date: March 2024
 | 
Report Format: PDF

Download Free PDF

Tacrolimus Market Share

The tacrolimus industry is competitive in nature, with several large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel advanced products based on different formulations is among a key market strategy. Some of the leading industry players including Abbott Laboratories, Astellas Pharma Inc., Novartis AG, Biocon Ltd., and Glenmark Pharmaceuticals Ltd. among others have a notable presence in the market.

 

Tacrolimus Market Companies

Some of the eminent market participants operating in the tacrolimus industry include:

  • Abbott Laboratories
  • Astellas Pharma Inc.
  • Biocon Ltd.
  • F. Hoffmann-La Roche Ltd
  • Glenmark Pharmaceuticals Ltd.
  • GSK plc
  • Lupin Pharmaceuticals Ltd
  • Novartis
  • Pfizer Inc.
  • Takeda Pharmaceutical Company Limited
  • Viatris Inc.
Authors: Mariam Faizullabhoy, Gauri Wani
Frequently Asked Question(FAQ) :
What is the size of the tacrolimus market?
The market size of tacrolimus reached USD 6.6 billion in revenue in 2023 and is set to witness 5.6% CAGR from 2024 to 2032, led by the rising number of organ transplant procedures and the increasing prevalence of autoimmune diseases.
Who are the major tacrolimus market participants?
How big is the North America tacrolimus industry?
Why is the demand for tacrolimus injections increasing?
Related Reports
    Authors: Mariam Faizullabhoy, Gauri Wani
    Buy Now
    $4,123 $4,850
    15% off
    $4,840 $6,050
    20% off
    $5,145 $7,350
    30% off
        Buy now
    Premium Report Details

    Base Year: 2023

    Companies covered: 11

    Tables & Figures: 188

    Countries covered: 22

    Pages: 110

    Download Free PDF

    Top